Ubs Group Ag Sqz Biotechnologies CO Transaction History

Ubs Group Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.27 - $0.68 $327 - $825	-1,214 Reduced 46.27%	1,410 $0
Q1 2023 May 12, 2023	BUY	$0.53 - $0.87 $1,390 - $2,282	2,624 New	2,624 $1,000
Q3 2022 Nov 10, 2022	BUY	$2.16 - $3.48 $743 - $1,197	344 Added 11.49%	3,337 $8,000
Q2 2022 Aug 10, 2022	BUY	$2.77 - $5.0 $8,290 - $14,965	2,993 New	2,993 $10,000
Q1 2022 May 16, 2022	SELL	$4.01 - $10.42 $57,250 - $148,766	-14,277 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.93 - $14.85 $64,983 - $108,063	7,277 Added 103.96%	14,277 $128,000
Q3 2021 Nov 15, 2021	BUY	$11.46 - $15.77 $37,050 - $50,984	3,233 Added 85.82%	7,000 $101,000
Q2 2021 Aug 13, 2021	BUY	$11.32 - $14.45 $26,194 - $33,437	2,314 Added 159.26%	3,767 $54,000
Q1 2021 May 12, 2021	BUY	$12.07 - $29.9 $6,312 - $15,637	523 Added 56.24%	1,453 $20,000
Q4 2020 Feb 11, 2021	BUY	$13.25 - $34.58 $12,322 - $32,159	930 New	930 $27,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.